Kurt Blaser

Articles in Scholarly Journals [Incomplete List]

  1. Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: Potential role of histamine in airway remodeling
    Journal of Allergy and Clinical Immunology, vol. 119, no. 6, pp. 1398–1407, 2007
  2. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain—containing protein tyrosine phosphatase 1
    Journal of Allergy and Clinical Immunology, vol. 120, no. 1, pp. 76–83, 2007
  3. Comparison of Der p1-specific antibody levels in children with allergic airway disease and healthy controls
    Pediatric Allergy and Immunology, vol. 18, no. 4, pp. 320–325, 2007
  4. High-Altitude Climate Therapy Reduces Local Airway Inflammation and Modulates Lymphocyte Activation
    Scandinavian Journal of Immunology, vol. 63, no. 4, pp. 304–310, 2006
  5. Mechanisms of allergen specific immunotherapy - T-cell tolerance and more
    Allergy, vol. 61, no. 7, pp. 796–807, 2006
  6. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells
    Immunology, vol. 117, no. 4, pp. 433–442, 2006
  7. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study
    Clinical Experimental Allergy, vol. 36, no. 2, pp. 211–218, 2006
  8. Mechanisms of Allergen-Specific Immunotherapy: T-Regulatory Cells and More
    Immunology and Allergy Clinics of North America, vol. 26, no. 2, pp. 207–231, 2006
  9. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-ß–mediated airway remodeling in asthma
    Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 111–118, 2006
  10. Absence of T-regulatory cell expression and function in atopic dermatitis skin
    Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 176–183, 2006
  11. Histamine Receptors in Immune Regulation and Allergen-Specific Immunotherapy
    Immunology and Allergy Clinics of North America, vol. 26, no. 2, pp. 245–259, 2006
  12. The Role of TGF-² in Allergic Inflammation
    Immunology and Allergy Clinics of North America, vol. 26, no. 2, pp. 233–244, 2006
  13. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 andIL-26
    European Journal of Immunology, vol. 36, no. 2, pp. 380–388, 2006
  14. TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes
    AJP: Lung Cellular and Molecular Physiology, vol. 291, no. 4, pp. L747–L756, 2006
  15. Clinical and Molecular Allergy, vol. 4, no. 1, p. 9, 2006
  16. Impact of Sublingual Immunotherapy on Specific Antibody Levels in Asthmatic Children Allergic to House Dust Mites
    International Archives of Allergy and Immunology, vol. 136, no. 3, pp. 287–294, 2005
  17. Histamine in Allergic Inflammation and Immune Modulation
    International Archives of Allergy and Immunology, vol. 137, no. 1, pp. 82–92, 2005
  18. Apoptosis and Loss of Adhesion of Bronchial Epithelial Cells in Asthma
    International Archives of Allergy and Immunology, vol. 138, no. 2, pp. 142–150, 2005
  19. Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes
    European Journal of Immunology, vol. 35, no. 11, pp. 3268–3276, 2005
  20. The role of the FOXP3 transcription factor in the immune regulation of allergic asthma
    Current Allergy and Asthma Reports, vol. 5, no. 5, pp. 356–361, 2005
  21. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy
    Journal of Allergy and Clinical Immunology, vol. 115, no. 2, pp. 323–329, 2005
  22. IgE-mediated and T cell–mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis
    Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 1068–1075, 2005
  23. T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
    Journal of Allergy and Clinical Immunology, vol. 116, no. 5, pp. 961–968, 2005
  24. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA
    Pediatric Allergy and Immunology, vol. 16, no. 3, pp. 217–225, 2005
  25. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells
    Clinical and Experimental Immunology, vol. 140, no. 2, pp. 301–309, 2005
  26. Distinct Leucocyte Redistribution After Glucocorticoid Treatment Among Difficult-to-Treat Asthmatic Patients
    Scandinavian Journal of Immunology, vol. 61, no. 2, pp. 187–196, 2005
  27. T Regulatory Cells in Allergen-Specific Immunotherapy
    International Reviews Of Immunology, vol. 24, no. 5-6, pp. 533–548, 2005
  28. TGF-  signaling of human T cells is modulated by the ancillary TGF-  receptor endoglin
    International Immunology, vol. 17, no. 7, pp. 921–930, 2005
  29. Mechanisms of Allergen Immunotherapy
    Allergy & Clinical Immunology International - Journal of the World Allergy Organization, vol. 16, no. 02, pp. 65–69, 2004
  30. Apoptosis in tissue inflammation and allergic disease
    Current Opinion in Immunology, vol. 16, no. 6, pp. 717–723, 2004
  31. Mechanisms of allergen immunotherapy
    Clinical Experimental Allergy Reviews, vol. 4, no. s2, pp. 56–60, 2004
  32. Discussuion Session 2. Genetic factors and immune tolerance in allergic disorders
    Clinical Experimental Allergy Reviews, vol. 4, no. s2, pp. 61–63, 2004
  33. Discussuion Session 6. Chemotactic receptors, cytokines and chemokines
    Clinical Experimental Allergy Reviews, vol. 4, no. s2, pp. 171–175, 2004
  34. Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells
    Journal of Experimental Medicine, vol. 199, no. 11, pp. 1567–1575, 2004
  35. Interleukin-10, T regulatory cells and specific allergy treatment
    Clinical Experimental Allergy, vol. 34, no. 3, pp. 328–331, 2004
  36. Regulation and role of transforming growth factor-? in immune tolerance induction and inflammation
    Current Opinion in Immunology, vol. 16, no. 6, pp. 709–716, 2004
  37. Current Opinion in Immunology, vol. 16, no. 6, pp. 685–688, 2004
  38. Glucocorticoids upregulate expression and regulatory T cells in asthma
    Journal of Allergy and Clinical Immunology, vol. 114, no. 6, pp. 1425–1433, 2004
  39. Immunological mechanisms in specific immunotherapy
    Springer Seminars in Immunopathology, vol. 25, no. 3-4, pp. 377–390, 2004
  40. Genes of tolerance
    Allergy, vol. 59, no. 9, pp. 897–913, 2004
  41. Discussuion Session 9. Immune therapy and prevention: is it just around the corner?
    Clinical Experimental Allergy Reviews, vol. 4, no. s2, pp. 242–245, 2004
  42. T Cell Phenotype in Allergic Asthma and Atopic Dermatitis
    International Archives of Allergy and Immunology, vol. 131, no. 4, pp. 272–282, 2003
  43. IL-10 Controls Aspergillus fumigatus- and Pseudomonas aeruginosa-Specific T-Cell Response in Cystic Fibrosis
    Pediatric Research, vol. 53, no. 2, pp. 313–319, 2003
  44. IL-10 and TGF-ß cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
    European Journal of Immunology, vol. 33, no. 5, pp. 1205–1214, 2003
  45. Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides
    European Journal of Immunology, vol. 33, no. 10, pp. 2717–2726, 2003
  46. Nuclear transport factor 2 represents a novel cross-reactive fungal allergen
    Allergy, vol. 58, no. 3, pp. 198–206, 2003
  47. Phage display of human antibodies from a patient suffering from coeliac disease and selection of isotype-specific scFv against gliadin
    Immunology, vol. 110, no. 2, pp. 269–274, 2003
  48. Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation
    Immunology, vol. 108, no. 3, pp. 305–312, 2003
  49. Immunoglobulin E-binding and skin test reactivity to hydrophobin HCh-1 from Cladosporium herbarum, the first allergenic cell wall component of fungi
    Clinical Experimental Allergy, vol. 33, no. 1, pp. 72–77, 2003
  50. In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract
    Clinical Experimental Allergy, vol. 33, no. 8, pp. 1153–1158, 2003
  51. Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy
    Journal of Allergy and Clinical Immunology, vol. 111, no. 6, pp. 1328–1336, 2003
  52. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells
    The FASEB Journal, vol. 17, no. 9, pp. 1026–1035, 2003
  53. Histamine in the immune regulation of allergic inflammation?
    Journal of Allergy and Clinical Immunology, vol. 112, no. 1, pp. 15–22, 2003
  54. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression
    The FASEB Journal, vol. 17, no. 2, pp. 194–202, 2003
  55. Histamine enhances TGF-beta1-mediated suppression of Th2 responses
    The FASEB Journal, vol. 17, no. 9, pp. 1089–1095, 2003
  56. T Cells and Effector Functions in Atopic Dermatitis
    Allergy & Clinical Immunology International - Journal of the World Allergy Organization, vol. 14, no. 4, pp. 161–164, 2002
  57. T-cell tolerance in allergic response
    Allergy, vol. 57, no. 9, pp. 762–768, 2002
  58. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma
    Journal of Allergy and Clinical Immunology, vol. 109, no. 2, pp. 329–337, 2002
  59. Immune regulation by histamine
    Current Opinion in Immunology, vol. 14, no. 6, pp. 735–740, 2002
  60. Human NK1 and NK2 subsets determined by purification of IFN-?-secreting and IFN-?-nonsecreting NK cells
    European Journal of Immunology, vol. 32, no. 3, p. 879, 2002
  61. Cyclophilins, a new family of cross-reactive allergens
    European Journal of Immunology, vol. 32, no. 1, pp. 10–17, 2002
  62. TGF-β-mediated control of allergen-specific t-cell responses
    Current Allergy and Asthma Reports, vol. 2, no. 3, pp. 259–262, 2002
  63. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells
    European Journal of Immunology, vol. 32, no. 4, pp. 1196–1204, 2002
  64. T cells and effector mechanisms in the pathogenesis of atopic dermatitis
    Current Allergy and Asthma Reports, vol. 2, no. 1, pp. 1–3, 2002
  65. Immunological and Structural Analysis of IgE-Mediated Cross-Reactivity between Manganese Superoxide Dismutases
    International Archives of Allergy and Immunology, vol. 128, no. 4, pp. 292–303, 2002
  66. Predictors of Methacholine Responsiveness in a General Population*
    Chest, vol. 122, no. 3, pp. 812–820, 2002
  67. Allergy and immunity to fungal infections and colonization
    European Respiratory Journal, vol. 19, no. 1, pp. 151–157, 2002
  68. Histamine Upregulates Th1 and Downregulates Th2 Responses due to Different Patterns of Surface Histamine 1 and 2 Receptor Expression
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 190–192, 2001
  69. Induction of Blocking Antibodies with T Cell Epitope-Containing Hypoallergenic Recombinant Bet v 1 Fragments
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 107–108, 2001
  70. Mechanism of IL-10-Induced T Cell Inactivation in Allergic Inflammation and Normal Response to Allergens
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 180–182, 2001
  71. Role of Apoptosis in Atopic Dermatitis
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 230–232, 2001
  72. Tapping Allergen Repertoires by Advanced Cloning Technologies
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 43–47, 2001
  73. Purified Recombinant A. fumigatus Allergens Induce Different Responses in Mice
    Clinical Immunology, vol. 98, no. 3, pp. 327–336, 2001
  74. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis
    Trends in Immunology, vol. 22, no. 10, pp. 530–532, 2001
  75. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens
    Microbes and Infection, vol. 3, no. 11, pp. 891–898, 2001
  76. Bypassing IgE and targeting T cells for specific immunotherapy of allergy
    Trends in Immunology, vol. 22, no. 4, pp. 175–178, 2001
  77. Mechanisms of interleukin-10-mediated immune suppression
    Immunology, vol. 103, no. 2, pp. 131–136, 2001
  78. Cytokine network and dysregulated apoptosis in atopic dermatitis
    Acta Odontologica Scandinavica, vol. 59, no. 3, pp. 178–182, 2001
  79. Nature, vol. 413, no. 6854, pp. 420–425, 2001
  80. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils
    Clinical Experimental Allergy, vol. 31, no. 8, pp. 1310–1320, 2001
  81. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis
    Journal of Allergy and Clinical Immunology, vol. 108, no. 5, pp. 839–846, 2001
  82. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response
    Journal of Allergy and Clinical Immunology, vol. 108, no. 6, pp. 954–961, 2001
  83. Clinical and Immunological Features of Patients with Interleukin-5-Producing T Cell Clones and Eosinophilia
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 242–245, 2001
  84. Regulation of Allergic Inflammation by T Cells and Cytokines in Atopic Dermatitis
    International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 296–298, 2001
  85. DNA Arrays in Allergy and Immunology
    International Archives of Allergy and Immunology, vol. 126, no. 1, pp. 1–10, 2001
  86. The Differential Fate of Cadherins during T-Cell-Induced Keratinocyte Apoptosis Leads to Spongiosis in Eczematous Dermatitis
    Journal of Investigative Dermatology, vol. 117, no. 4, pp. 927–934, 2001
  87. Erratum
    The FASEB Journal, vol. 14, no. 13, pp. 2128–2128, 2000
  88. Regulation of Specific Immune Responses by Chemical and Structural Modifications of Allergens
    International Archives of Allergy and Immunology, vol. 121, no. 4, pp. 261–269, 2000
  89. APOPTOSIS, vol. 5, no. 5, pp. 425–429, 2000
  90. Effect of 3 weeks' rehabilitation on neutrophil surface antigens and lung function in cystic fibrosis
    European Respiratory Journal, vol. 15, no. 5, pp. 942–948, 2000
  91. Specific peptide immunotherapy
    Revue Française d'Allergologie et d'Immunologie Clinique, vol. 40, no. 3, pp. 309–317, 2000
  92. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA
    Clinical Experimental Allergy, vol. 30, no. 7, pp. 988–993, 2000
  93. Mechanisms of allergen-specific immunotherapy
    Allergy, vol. 55, no. 6, pp. 522–530, 2000
  94. Immune regulation in atopic dermatitis
    Current Opinion in Immunology, vol. 12, no. 6, pp. 641–646, 2000
  95. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway
    European Journal of Immunology, vol. 30, no. 6, pp. 1683–1690, 2000
  96. Expression of cutaneous lymphocyte-associated antigen on human CD4+ and CD8+ Th2 cells
    European Journal of Immunology, vol. 30, no. 12, pp. 3533–3541, 2000
  97. Immunologische Grundlagen des Asthma bronchiale
    Der Internist, vol. 40, no. 8, pp. 849–854, 1999
  98. IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1
    Journal of Allergy and Clinical Immunology, vol. 104, no. 2, pp. 478–484, 1999
  99. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif
    Immunology, vol. 96, no. 1, pp. 1–9, 1999
  100. Skin test reactivity to 2 recombinant allergens in –sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization
    Journal of Allergy and Clinical Immunology, vol. 104, no. 3, pp. 601–607, 1999
  101. Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic Eosinophilia
    New England Journal of Medicine, vol. 341, no. 15, pp. 1112–1120, 1999
  102. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
    Proceedings of the National Academy of Sciences, vol. 96, no. 23, pp. 13330–13335, 1999
  103. IgE–Mediated Reactions to Autoantigens in Allergic Diseases
    International Archives of Allergy and Immunology, vol. 118, no. 2-4, pp. 193–196, 1999
  104. T Cells and T Cell-Derived Cytokines as Pathogenic Factors in the Nonallergic Form of Atopic Dermatitis
    Journal of Investigative Dermatology, vol. 113, no. 4, pp. 628–634, 1999
  105. Regulation of Allergic Inflammation by Skin–Homing T Cells in Allergic Eczema
    International Archives of Allergy and Immunology, vol. 118, no. 2-4, pp. 140–144, 1999
  106. Humoral and Cell-mediated Autoimmune Reactions to Human Acidic Ribosomal P2 Protein in Individuals Sensitized to Aspergillus fumigatus P2 Protein
    Journal of Experimental Medicine, vol. 189, no. 9, pp. 1507–1512, 1999
  107. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop�).
    Allergy, vol. 53, no. 6, pp. 608–613, 1998
  108. Determinants and Mechanisms of Human Immune Responses to Bee Venom Phospholipase A2
    International Archives of Allergy and Immunology, vol. 117, no. 1, pp. 1–10, 1998
  109. Disruption of Fas Receptor Signaling by Nitric Oxide in Eosinophils
    Journal of Experimental Medicine, vol. 187, no. 3, pp. 415–425, 1998
  110. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
    International Immunology, vol. 10, no. 8, pp. 1211–1216, 1998
  111. Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy
    Clinical Experimental Allergy, vol. 28, no. 7, pp. 839–849, 1998
  112. Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus
    Clinical Experimental Allergy, vol. 28, no. 7, pp. 860–867, 1998
  113. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
    Journal of Allergy and Clinical Immunology, vol. 101, no. 6, pp. 747–754, 1998
  114. Differential IgE recognition of recombinantAspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis orAspergillus allergy
    European Journal of Immunology, vol. 28, no. 4, pp. 1155–1160, 1998
  115. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants
    European Journal of Immunology, vol. 28, no. 3, pp. 914–925, 1998
  116. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells
    European Journal of Immunology, vol. 27, no. 2, pp. 515–521, 1997
  117. Molecular parameters in melittin immunogenicity
    Journal of Peptide Science, vol. 3, no. 4, pp. 267–276, 1997
  118. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
    European Journal of Immunology, vol. 27, no. 12, pp. 3536–3539, 1997
  119. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cellsin vitro
    European Journal of Immunology, vol. 27, no. 9, pp. 2351–2357, 1997
  120. Induction and differential regulation of bee venom phospholipase A2â??specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cellsâ??, â??â??, â??, â??â??
    Journal of Allergy and Clinical Immunology, vol. 99, no. 3, pp. 345–353, 1997
  121. SAPALDIA: Methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults
    Sozial- und Pr�ventivmedizin SPM, vol. 42, no. 2, pp. 67–84, 1997
  122. Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2
    Clinical Experimental Allergy, vol. 27, no. 8, pp. 915–920, 1997
  123. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma
    Allergy, vol. 52, no. 2, pp. 144–154, 1997
  124. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia CAP System
    Clinical Experimental Allergy, vol. 26, no. 12, pp. 1411–1419, 1996
  125. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor
    Journal of Experimental Medicine, vol. 184, no. 1, pp. 191–201, 1996
  126. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus
    Journal of Experimental Medicine, vol. 184, no. 1, pp. 265–270, 1996
  127. Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia
    Journal of Experimental Medicine, vol. 183, no. 3, pp. 1071–1082, 1996
  128. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils
    Journal of Experimental Medicine, vol. 183, no. 4, pp. 1407–1414, 1996
  129. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells
    European Journal of Immunology, vol. 26, no. 9, pp. 2056–2061, 1996
  130. A strict requirement of interleukin-4 for interleukin-4 induction in antigen-stimulated human memory T cells
    European Journal of Immunology, vol. 26, no. 8, pp. 1860–1865, 1996
  131. Expression and function of the Fas receptor on human blood and tissue eosinophils
    European Journal of Immunology, vol. 26, no. 8, pp. 1775–1780, 1996
  132. Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients
    European Journal of Immunology, vol. 25, no. 2, pp. 538–542, 1995
  133. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
    Immunology Today, vol. 16, no. 2, pp. 53–55, 1995
  134. Type I skin reactivity to native and recombinant phospholipase A from honeybee venom is similar
    Journal of Allergy and Clinical Immunology, vol. 96, no. 3, pp. 395–402, 1995
  135. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen
    Journal of Experimental Medicine, vol. 181, no. 5, pp. 1935–1940, 1995
  136. Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH-1 or TH-2-like cytokine patterns
    Clinical Experimental Allergy, vol. 25, no. 11, pp. 1108–1117, 1995
  137. Variability of FVC and FEV1 due to technician, team, device and subject in an eight centre study: three quality control studies in SAPALDIA
    European Respiratory Journal, vol. 8, no. 3, pp. 371–376, 1995
  138. Display of Expression Products of cDNA Libraries on Phage Surfaces. A Versatile Screening System for Selective Isolation of Genes by Specific Gene-Product/Ligand Interaction
    European Journal of Biochemistry, vol. 226, no. 1, pp. 53–58, 1994
  139. Protein-Tyrosine Phosphorylation Regulates Apoptosis in Human Eosinophils and Neutrophils
    Proceedings of the National Academy of Sciences, vol. 91, no. 23, pp. 10868–10872, 1994
  140. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma
    Pediatric Pulmonology, vol. 17, no. 5, pp. 304–311, 1994
  141. Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A
    Journal of Allergy and Clinical Immunology, vol. 94, no. 1, pp. 61–70, 1994
  142. Regulation of IgE and IgG responses by allergen specific T-cell clones to bee venom phospholipase A in vitro
    Journal of Allergy and Clinical Immunology, vol. 93, no. 4, pp. 758–767, 1994
  143. Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: A longitudinal study in bronchial asthma
    Journal of Allergy and Clinical Immunology, vol. 94, no. 2, pp. 240–249, 1994
  144. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
    Arthritis & Rheumatism, vol. 37, no. 4, pp. 568–571, 1994
  145. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore
    European Journal of Immunology, vol. 23, no. 4, pp. 956–960, 1993
  146. Fine specificity and VJ usage of light chains in antibodies to the phosphorylcholine hapten
    European Journal of Immunology, vol. 23, no. 1, pp. 124–130, 1993
  147. Specific V gene usage in anti-phosphorylcholine ige antibodies*1
    Molecular Immunology, vol. 30, no. 17, pp. 1573–1582, 1993
  148. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity
    Clinical